Compare · BTSG vs HIMS
BTSG vs HIMS
Side-by-side comparison of BrightSpring Health Services Inc. (BTSG) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTSG and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- BTSG is the larger of the two at $11.78B, about 1.8x HIMS ($6.43B).
- Over the past year, BTSG is up 208.0% and HIMS is down 56.2% - BTSG leads by 264.2 points.
- BTSG has been more active in the news (6 items in the past 4 weeks vs 5 for HIMS).
- HIMS has more recent analyst coverage (25 ratings vs 23 for BTSG).
- Company
- BrightSpring Health Services Inc.
- Hims & Hers Health Inc.
- Price
- $59.65-18.11%
- $27.77+2.74%
- Market cap
- $11.78B
- $6.43B
- 1M return
- -14.64%
- -26.01%
- 1Y return
- +208.03%
- -56.19%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2024
- 2019
- News (4w)
- 6
- 5
- Recent ratings
- 23
- 25
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest BTSG
- SEC Form 10-Q filed by BrightSpring Health Services Inc.
- BrightSpring Health Services Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
- Officer Rousseau Jon B covered exercise/tax liability with 56,319 shares, decreasing direct ownership by 5% to 1,138,184 units (SEC Form 4) to cover withholding tax
- BrightSpring Health Services Set to Join S&P MidCap 400 and Karman Holdings to Join S&P SmallCap 600
- Guggenheim initiated coverage on BrightSpring Health Services with a new price target
- Raymond James initiated coverage on BrightSpring Health Services with a new price target
- BrightSpring Health Services, Inc. to Announce Second Quarter 2026 Financial Results on July 31, 2026
- President, PharMerica Greenwell Scott A. covered exercise/tax liability with 2,487 shares, decreasing direct ownership by 7% to 34,372 units (SEC Form 4) to satisfy withholding obligation
- Director Shah Nigam H. was granted 4,013 shares (SEC Form 4)
Latest HIMS
- Hims & Hers Responds to FTC Lawsuit
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $229,168 worth of shares (7,163 units at $31.99) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax